[Close]Chrome, Firefox and Edge do not support opening, entering data and saving this type of PDF in the browser. Save to your computer and use Adobe Acrobat Reader for full functionality. The "Please wait…" message you may get when clicking on it is an error message in disguise.

To download from the "Please wait" page, move your cursor to the top right, click on the download icon, and choose where to save it on your computer. Once saved, you will be able to open with Adobe Acrobat Reader and use all of the features of the action plan. Email info@GetAsthmaHelp.org for more help.

Asthma News – October 4, 2022

Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails.

Check out the most recent MDHHS asthma social media messages and share them with your networks.

Webinar: E-cigarettes (ENDS) and Novel Tobacco Products: Use and Cessation - 10/18 @ 1 p.m.

This webinar will help you: gain understanding of the changing landscape of tobacco and nicotine products when assessing patients; assess the latest evidence on ENDS safety, health impact and cessation efficacy; describe the unique aspects in assessing use behaviors and nicotine dependence for ENDS users, and; develop evidence-based strategies to assist with ENDS cessation.

Children’s Health Fund – New Family Asthma Guide

This child-friendly, colorful guide explains what asthma is, what triggers it, and how an asthma management plan can help. It is available for free in Adobe Acrobat PDF format in both English and Spanish.

Asthma control with inhaled corticosteroid (ICS)-formoterol reliever versus maintenance ICS and SABA reliever therapy

Researchers found no clinically important differences in the proportions of patients with ‘well-controlled’ or ‘partly controlled’ asthma symptoms, or proportions who improved or maintained their level of control, with as-needed budesonide–formoterol versus maintenance budesonide plus short-acting beta2-agonist (SABA).

Asthma, Anxiety and More Linked to Medical Debt

Heart disease, asthma, and anxiety disorders were the chronic conditions most strongly associated with medical debt in lower-income households.

Asthma exacerbations are associated with a decline in lung function

A large population-based study found that more frequent asthma exacerbations are associated with faster lung function decline. This was more prominent in younger patients but was evident in older patients when it was related to lower starting lung function, suggesting a persistent deteriorating phenotype that develops in adulthood over time.

Tezepelumab compared with other biologics for the treatment of severe asthma

A new systematic review and indirect treatment comparison of 16 randomized controlled trials supports the use of tezepelumab in a broad patient population of severe uncontrolled asthma of any phenotype.